These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600 [TBL] [Abstract][Full Text] [Related]
28. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy? Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852 [TBL] [Abstract][Full Text] [Related]
29. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia. Gertz MA; Kyle RA; Noel P J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054 [TBL] [Abstract][Full Text] [Related]
30. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Hamer JP; Janssen S; van Rijswijk MH; Lie KI Eur Heart J; 1992 May; 13(5):623-7. PubMed ID: 1618203 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography. Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084 [TBL] [Abstract][Full Text] [Related]
33. Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Ueno S; Fujimura H; Yorifuji S; Nakamura Y; Takahashi M; Tarui S; Yanagihara T Brain; 1992 Oct; 115 ( Pt 5)():1275-89. PubMed ID: 1330202 [TBL] [Abstract][Full Text] [Related]
38. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902 [TBL] [Abstract][Full Text] [Related]
39. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation. Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593 [TBL] [Abstract][Full Text] [Related]
40. Familial amyloid cardiomyopathy masquerading as chronic Guillain-Barre syndrome: things are not always what they seem. Hu D; Liu L; Yuan S; Yi Y; Peng D Front Med; 2017 Jun; 11(2):293-296. PubMed ID: 28425041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]